These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 30885099)
21. Synthesis, DNA/HSA Interaction Spectroscopic Studies and In Vitro Cytotoxicity of a New Mixed Ligand Cu(II) Complex. Gan Q; Fu X; Chen W; Xiong Y; Fu Y; Chen S; Le X J Fluoresc; 2016 May; 26(3):905-18. PubMed ID: 26961845 [TBL] [Abstract][Full Text] [Related]
22. Biological evaluation, molecular docking and DNA interaction studies of coordination compounds gleaned from a pyrazolone incorporated ligand. Arunadevi A; Porkodi J; Ramgeetha L; Raman N Nucleosides Nucleotides Nucleic Acids; 2019; 38(9):656-679. PubMed ID: 30990358 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes. Wang Q; Mao H; Wang W; Zhu H; Dai L; Chen Y; Tang X Biometals; 2017 Aug; 30(4):575-587. PubMed ID: 28616784 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of copper-based anticancer compound; Al-Asbahy WM; Shamsi M J Biomol Struct Dyn; 2021 Mar; 39(4):1431-1446. PubMed ID: 32090687 [TBL] [Abstract][Full Text] [Related]
26. Water soluble ionic Co(II), Cu(II) and Zn(II) diimine-glycinate complexes targeted to tRNA: structural description, Zehra S; Gómez-Ruiz S; Siddique HR; Tabassum S; Arjmand F Dalton Trans; 2020 Dec; 49(46):16830-16848. PubMed ID: 33179662 [TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Biological Evaluation of Benzimidazole-Derived Biocompatible Copper(II) and Zinc(II) Complexes as Anticancer Chemotherapeutics. AlAjmi MF; Hussain A; Rehman MT; Khan AA; Shaikh PA; Khan RA Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772746 [TBL] [Abstract][Full Text] [Related]
28. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity. Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes. Ajibade PA; Andrew FP; Botha NL; Solomane N Molecules; 2020 Aug; 25(16):. PubMed ID: 32781741 [TBL] [Abstract][Full Text] [Related]
30. New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines. Tabassum S; Afzal M; Arjmand F Eur J Med Chem; 2014 Mar; 74():694-702. PubMed ID: 24268597 [TBL] [Abstract][Full Text] [Related]
31. Studies on some metal complexes of quinoxaline based unsymmetric ligand: Synthesis, spectral characterization, in vitro biological and molecular modeling studies. Dhanaraj CJ; Johnson J J Photochem Photobiol B; 2016 Aug; 161():108-21. PubMed ID: 27236046 [TBL] [Abstract][Full Text] [Related]
32. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity. Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180 [TBL] [Abstract][Full Text] [Related]
33. Tris-chelated complexes of nickel(II) with bipyridine derivatives: DNA binding and cleavage, BSA binding, molecular docking, and cytotoxicity. Anjomshoa M; Torkzadeh-Mahani M; Sahihi M; Rizzoli C; Ansari M; Janczak J; Sherafat Esfahani S; Ataei F; Dehkhodaei M; Amirheidari B J Biomol Struct Dyn; 2019 Sep; 37(15):3887-3904. PubMed ID: 30309295 [TBL] [Abstract][Full Text] [Related]
34. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study. Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692 [TBL] [Abstract][Full Text] [Related]
35. Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of Khursheed S; Siddique HR; Tabassum S; Arjmand F Dalton Trans; 2022 Aug; 51(31):11713-11729. PubMed ID: 35852297 [TBL] [Abstract][Full Text] [Related]
36. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand. Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the anticancer activities with various ligand substituents in Co(II/III)-picolyl phenolate derivatives: synthesis, characterization, DFT, DNA cleavage, and molecular docking studies. Jana A; Aher A; Brandao P; Bera P; Sharda S; Phadikar U; Manna SK; Mahapatra AK; Bera P Dalton Trans; 2022 Feb; 51(6):2346-2363. PubMed ID: 35043134 [TBL] [Abstract][Full Text] [Related]
38. Novel Bioactive Co(II), Cu(II), Ni(II) and Zn(II) Complexes with Schiff Base Ligand Derived from Histidine and 1,3-Indandione: Synthesis, Structural Elucidation, Biological Investigation and Docking Analysis. Dhayabaran VV; Prakash TD; Renganathan R; Friehs E; Bahnemann DW J Fluoresc; 2017 Jan; 27(1):135-150. PubMed ID: 27696010 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes. Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305 [TBL] [Abstract][Full Text] [Related]